Hosted on MSN

Oxide reduces potential dilution as 3rd-series stock options expire and are partially exercised

OXIDE Corp. ( (JP:6521)) has provided an announcement. OXIDE Corporation reported the December 2025 exercise status of its 3rd series stock acquisition rights, with 7,000 shares delivered through the ...
Nasdaq

Incannex Healthcare Inc. Enters Agreement to Cancel Remaining Series A Warrants, Eliminating Up to 347.2 Million Shares from Potential Dilution Ahead of IHL-42X Phase 2 Topline ...

MELBOURNE, Australia and NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company advancing combination drug therapies for ...